Russell Investments Group
CNCE

Russell Investments Group’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Russell Investments Group’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-42,976
Closed -$139K – 3143
2021
Q3 		$139K Sell
42,976
-6,198
-13% -$21.7K ﹤0.01% 2836
2021
Q2 		$206K Sell
49,174
-36,890
-43% -$156K ﹤0.01% 2901
2021
Q1 		$428K Sell
86,064
-35,742
-29% -$289K ﹤0.01% 2587
2020
Q4 		$1.54M Sell
121,806
-46,334
-28% -$528K ﹤0.01% 1895
2020
Q3 		$1.65M Sell
168,140
-3,323
-2% -$32.7K ﹤0.01% 1808
2020
Q2 		$1.7M Buy
171,463
+23,410
+16% +$225K ﹤0.01% 1736
2020
Q1 		$1.31M Buy
148,053
+68,172
+85% +$672K ﹤0.01% 1707
2019
Q4 		$736K Sell
79,881
-46,222
-37% -$328K ﹤0.01% 2255
2019
Q3 		$742K Buy
126,103
+109,928
+680% +$1.17M ﹤0.01% 2140
2019
Q2 		$194K Buy
+16,175
New +$174K ﹤0.01% 2522
2019
Q1 		– Sell
-94,650
Closed -$1.19M – 3049
2018
Q4 		$1.19M Sell
94,650
-22,849
-19% -$315K ﹤0.01% 1864
2018
Q3 		$1.75M Buy
117,499
+39,692
+51% +$624K ﹤0.01% 1822
2018
Q2 		$1.31M Sell
77,807
-86,911
-53% -$1.69M ﹤0.01% 1974
2018
Q1 		$3.77M Buy
164,718
+135,340
+461% +$3.01M 0.01% 1511
2017
Q4 		$760K Buy
+29,378
New +$592K ﹤0.01% 2273
2017
Q1 		– Sell
-42,704
Closed -$440K – 3111
2016
Q4 		$440K Buy
+42,704
New +$390K ﹤0.01% 2513

Other funds holding CNCE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Russell Investments Group's CNCE Position: Q4 2021 in Review

Russell Investments Group sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q4 2021, closing a stake of 42,976 shares — an estimated $139K sold.

Russell Investments Group first reported a position in CNCE in Q4 2016 and held it in 16 quarters. The position peaked at $3.77M in Q1 2018. 52 funds tracked by Wall St. Rank hold CNCE as of Q4 2021.

  • Russell Investments Group reported no remaining Concert Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
  • Russell Investments Group sold 42,976 Concert Pharmaceuticals, Inc. shares in Q4 2021, an estimated $139K.
  • Russell Investments Group first reported a position in Concert Pharmaceuticals, Inc. in Q4 2016 and held it in 16 quarters.
  • Russell Investments Group's Concert Pharmaceuticals, Inc. position peaked at $3.77M in Q1 2018.
  • 52 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q4 2021.

Based on Russell Investments Group's 13F filing for Q4 2021, filed 21 Jan 2022.